Novavax | NVAX - Market Capitalization


Novavax reported $1.45B in Market Capitalization this September of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Adma Biologics USD 2.15B 2.19B Mar/2026
Agenus USD 128M 21M Mar/2026
AstraZeneca USD 289.99B 11.26B Jun/2026
BioCryst Pharmaceuticals USD 2.54B 880M Jun/2026
Cassava Sciences USD 82M 14M Mar/2026
GlaxoSmithKline GBP 80.14B 3.66B Jun/2026
MannKind USD 1.32B 559M Jun/2026
Merck USD 317.37B 20.27B Jun/2026
Novartis USD 288.26B 25.18B Mar/2026
Novavax USD 1.09B 316M Dec/2025
Pfizer USD 138.44B 15.37B Jun/2026
Sanofi EUR 91.15B 9.12B Jun/2026
Sarepta Therapeutics USD 1.9B 388M Jun/2026
TG Therapeutics USD 8.41B 3.1B Jun/2026